Puma Biotechnology, Inc. (PBYI): Depreciation & Amortization
$10.94M
Year ended 2025-12-31
$10.48M
Trailing 12 months to 2026-06-30
+3.6%
3-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.94M | -5.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $11.52M | 0.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $11.52M | +17.1% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $9.84M | -13.0% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $11.30M | n/c | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $10.03M | +24.2% | 2023-03-02, From 2020-01-01 |
| 2019-12-31 | $8.08M | +9.4% | 2022-03-03, From 2019-01-01 |
| 2018-12-31 | $7.38M | +162.7% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $2.81M | +144.6% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $1.15M | +48.1% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $776.0K | +23.8% | 2018-03-09, From 2015-01-01 |
| 2014-12-31 | $627.0K | +48.2% | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $423.0K | +59.6% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $265.0K | n/m | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $11.0K | n/a | 2014-03-03, From 2011-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $10.94M | -5.1% |
| Anaptysbio, Inc (ANAB) | 2025-12-31 | $559.0K | -7.8% |
| IDEAYA Biosciences, Inc. (IDYA) | 2025-12-31 | $2.70M | +13.1% |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | $10.00M | 0.0% |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | $6.02M | -2.2% |
| Arvinas, Inc. (ARVN) | 2025-12-31 | $3.00M | -34.8% |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $33.77M | -4.2% |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | $16.11M | +535.0% |
| Harrow, Inc. (HROW) | 2025-12-31 | $1.92M | +3.5% |
Compare PBYI, ANAB, IDYA, RCUS side by side · Screen every company in Pharmaceutical Preparations ↗